Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.52 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11768943 | 0.97 | CA4 (0.55) | CA4OR51E2LMNACYP3A4TSHR | |
| Silver SCHEMBL9803480 | 0.94 | — | — | |
| SCHEMBL10789752 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL2512864 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL320248 | 0.94 | — | — | |
| SCHEMBL9651902 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL3154885 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL8953691 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL291843 | 0.94 | CA4 (0.52) | CA4OR51E2LMNACYP3A4TSHR | |
| SCHEMBL9251243 | 0.94 | CA4 (0.57) | CA4OR51E2LMNACYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115531355-A | Tranexamic acid gel plaster and preparation method thereof | 湖南科锐斯医药科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-110917290-A | Medicine for treating hyperplasia of mammary glands and preparation method thereof | 贵州康琦药械有限公司 | 2020-03-27 | — | — | CN | claimed |
| EP-3218956-B1 | FAST CHARGE APPARATUS FOR A BATTERY | INTEC ENERGY STORAGE CORP (CA) | 2019-08-07 | — | — | EP | claimed |
| EP-3218953-B1 | SECONDARY BATTERY WITH NON-AQUEOUS ELECTROLYTE | INTEC ENERGY STORAGE CORP (CA) | 2019-08-07 | — | — | EP | claimed |
| US-10084206-B2 | Fast charge apparatus for a battery | INTEC ENERGY STORAGE CORP. (CA) | 2018-09-25 | — | — | US | claimed |
| US-9912008-B2 | Electrical energy storage device with non-aqueous electrolyte | INTEC ENERGY STORAGE CORPORATION (CA) | 2018-03-06 | — | — | US | claimed |
| EP-3218953-A1 | ELECTRICAL ENERGY STORAGE DEVICE WITH NON-AQUEOUS ELECTROLYTE | Intec Energy Storage Corp. (CA) | 2017-09-20 | — | — | EP | claimed |
| EP-3218956-A1 | FAST CHARGE APPARATUS FOR A BATTERY | Intec Energy Storage Corp. (CA) | 2017-09-20 | — | — | EP | claimed |
| US-20150147661-A1 | FAST CHARGE APPARATUS FOR A BATTERY | INTEC ENERGY STORAGE CORP. (CA) | 2015-05-28 | — | — | US | claimed |
| US-20150147663-A1 | ELECTRICAL ENERGY STORAGE DEVICE WITH NON-AQUEOUS ELECTROLYTE | INTEC ENERGY STORAGE CORPORATION (CA) | 2015-05-28 | — | — | US | claimed |
| US-20040136941-A1 | Cosmetic and dermatological preparation for removing sebum or regulating sebum production | BEIERSDORF AG | 2004-07-15 | — | — | US | claimed |
| EP-1392398-A2 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR REMOVING AND REGULATING SEBUM | Beiersdorf AG (DE) | 2004-03-03 | — | — | EP | claimed |
| WO-2002092029-A2 | COSMETIC AND DERMATOLOGICAL PREPARATIONS FOR REMOVING AND REGULATING SEBUM | BEIERSDORF AG (DE) | 2002-11-21 | — | — | WO | claimed |
| EP-1172084-A2 | Cosmetic and dermatologic composition to eliminate sebum | Beiersdorf Aktiengesellschaft (DE) | 2002-01-16 | — | — | EP | claimed |
| EP-0521317-B1 | Bathing preparation containing soluble aluminium carboxylate | KAO CORP (JP) | 1997-04-09 | — | — | EP | claimed |
| US-5389678-A | Refreshing sensation to users | KAO CORPORATION (JP) | 1995-02-14 | — | — | US | claimed |
| US-5310758-A | Water soluble aluminum carboxylate; dissolvability; feel, freshness | KAO CORPORATION (JP) | 1994-05-10 | — | — | US | claimed |
| EP-0521317-A2 | Bathing preparation containing soluble aluminium carboxylate | Kao Corporation (JP) | 1993-01-07 | — | — | EP | claimed |
| CN-115531355-A | Tranexamic acid gel plaster and preparation method thereof | 湖南科锐斯医药科技有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-0521317-A2 | Bathing preparation containing soluble aluminium carboxylate | Kao Corporation (JP) | 1993-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040136941-A1 | Cosmetic and dermatological preparation for removing sebum or regulating sebum production | CUTA, TYR, HDAC5 | CA4 312/4885OR51E2 839/4885LMNA 4267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.